Literature DB >> 7599824

Sleep stage influences the hemodynamic response to obstructive apneas.

E Garpestad1, J Ringler, J A Parker, S Remsburg, J W Weiss.   

Abstract

Blood pressure (BP) rises at the termination of obstructive episodes in patients with sleep apnea. Although the relationship of these BP elevations to oxygen saturation (SaO2) and arousal has been explored, the influence of sleep stage is undefined. To examine the effects of sleep stage on the postapnea BP elevation, we enrolled 12 patients with obstructive sleep apnea (OSA), and successfully collected data from seven of these (all male). Subjects slept overnight in the sleep laboratory, with full sleep and respiratory monitoring. Arterial pressure was assessed continuously with a radial artery catheter (six patients) or with digital photoplethysmography (one patient). Apneas occurring in both rapid eye movement (REM) and non-rapid eye movement (NREM) sleep were matched for duration and degree of desaturation. When mean arterial pressure (MAP) at termination of apneas during NREM sleep associated with SaO2 nadirs 78 to 82% (NREM 80%) was compared with MAP following apneas in REM with the same SaO2 nadir (REM 80%), there was a significant difference (NREM 80% 122 +/- 15.3 mm Hg, REM 80% 132 +/- 11.0; p = 0.0109). We also analyzed the effect of oxygen desaturation on MAP during REM sleep, by comparing events with SaO2 nadirs of 78 to 82% with events with nadirs of < 75% (REM < 75%). In REM, further desaturation was associated with significant lengthening of the obstructive episodes and significantly higher postapnea BP increases (REM 75% 143 +/- 19.9 mm Hg, p = 0.0392). We conclude that sleep stage alters the hemodynamic response to obstructive apneas during sleep.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599824     DOI: 10.1164/ajrccm.152.1.7599824

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  The effect of simulated obstructive apnoea on intraocular pressure and pulsatile ocular blood flow in healthy young adults.

Authors:  P O Lundmark; G E Trope; J G Flanagan
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 2.  The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea.

Authors:  Valeria Bisogni; Martino F Pengo; Giuseppe Maiolino; Gian Paolo Rossi
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

3.  Optogenetic stimulation of c1 and retrotrapezoid nucleus neurons causes sleep state-dependent cardiorespiratory stimulation and arousal in rats.

Authors:  Stephen B G Abbott; Melissa B Coates; Ruth L Stornetta; Patrice G Guyenet
Journal:  Hypertension       Date:  2013-02-25       Impact factor: 10.190

4.  Obstructive sleep apnea during REM sleep and daytime cerebral functioning: A regional cerebral blood flow study using high-resolution SPECT.

Authors:  Andrée-Ann Baril; Katia Gagnon; Pauline Brayet; Jacques Montplaisir; Julie Carrier; Jean-Paul Soucy; Chantal Lafond; Hélène Blais; Caroline d'Aragon; Jean-François Gagnon; Nadia Gosselin
Journal:  J Cereb Blood Flow Metab       Date:  2018-11-22       Impact factor: 6.200

5.  Acute cardiovascular changes with obstructive events in children with sleep disordered breathing.

Authors:  Denise M O'Driscoll; Alison M Foster; Michelle L Ng; Joel S C Yang; Farhat Bashir; Gillian M Nixon; Margot J Davey; Vicki Anderson; Adrian M Walker; John Trinder; Rosemary S C Horne
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

6.  Association of Craniofacial and Upper Airway Morphology with Cardiovascular Risk in Adults with OSA.

Authors:  Li Zhang; Xiaolei Zhang; Yi Ming Li; Bo Yun Xiang; Teng Han; Yan Wang; Chen Wang
Journal:  Nat Sci Sleep       Date:  2021-10-01

7.  Comparison between blood pressure during obstructive respiratory events in REM and NREM sleep using pulse transit time.

Authors:  Aljohara S Almeneessier; Mana Alshahrani; Salih Aleissi; Omeima S Hammad; Awad H Olaish; Ahmed S BaHammam
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.